According to the research report titled ‘Global Knee Reconstruction Devices Market Size study, by Product (Cemented Implants, Cementless Implants, Partial Implants, Revision Implants) by End User (Orthopedic Clinics, Hospitals, ASCs) by Indication (Osteoarthritis, Rheumatoid Arthritis, Trauma, Others)and Regional Forecasts 2021-2027’, available with Market Study Report, global knee reconstruction devices market was worth USD 7.4 billion in 2020 and is expected to register 4.1% CAGR with a valuation of USD 9.8 billion over 2021- 2027.
 

Innovations in functionality and design of the product, upgradation of knee surgery instruments, and developments in visualization, sensors, and mobile applications to adopt 3D technologies for cost-effective production are catalyzing the growth of global knee reconstruction devices market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3930287/
 

For instance, Conformis Inc. announced iTotal PS, a customized total knee replacement surgery system that provides rebuilding procedures to suit human bodies, gained approval from The Department of Health (Australia) in March 2021.
 

For the unversed, knee reconstruction procedure is used to relocate the anterior cruciate ligament (ACL), which stabilizes the knee. Increasing instances of arthritis, knee pain, and knee accidents,  in tandem with rising research and innovations are propelling the industry outlook.
 

Elaborating on the negatives, squeezing pressure of knee repair equipment as well as cases of product recall have restrained the global knee reconstruction devices industry expansion to some extent in the recent times.
 

In terms of product gamut, the business domain is bifurcated into revision implants, partial implants, cementless implants, and cemented implants, whereas based on end user terrain, the industry vertical is fragmented into ASCs, hospitals, and orthopedic clinics. Speaking of indication, the market sphere is classified into trauma, rheumatoid arthritis, osteoarthritis, and others.
 

Moving on to regional terrain, North America held a considerable share in worldwide knee reconstruction devices industry in the recent past and is expected to record 6.1% CAGR through 2027, accredited to high lucrativeness of the product. The U.S. witnessed significant surge in joint reconstruction procedures, mostly hip and knee treatments, in the recent past, hence boosting the demand for devices.
 

Parallelly, Asia Pacific market is anticipated to record a significant annual growth rate through 2027, creditable to booming medical tourism, soaring occurrence of osteoarthritis, and increasing geriatric populace.
 

The competitive hierarchy of the industry is defined by companies such as Stryker Corporation, Smith & Nephew plc, United Orthopedic Corporation, Exactech Inc., Japan Medical Dynamic Marketing Inc., Zimmer Biomet, DePuy Synthes, Corin Group, DJO Global Inc., and Arthrex Inc. among others.